Fin Trust Capital Advisors, LLC Emergent Bio Solutions Inc. Transaction History

Fin Trust Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 10, 2020	SELL	$81.91 - $134.94 $270,303 - $445,302	-3,300 Closed	0 $0
Q2 2020 Sep 11, 2020	BUY	$54.33 - $89.52 $179,289 - $295,416	3,300 New	3,300 $261,000
Q2 2020 Aug 14, 2020	SELL	$54.33 - $89.52 $526,783 - $867,985	-9,696 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$49.34 - $68.76 $478,400 - $666,696	9,696 New	9,696 $562,000
Q1 2019 May 09, 2019	SELL	$48.23 - $66.16 $24,115 - $33,080	-500 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$55.63 - $73.24 $27,815 - $36,620	500 New	500 $30,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.